This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Promimic AB (publ)
Q32024
11/21/2024
Heidi Bader
CFO
Hello and welcome to Promimic's presentation of the results for the third quarter. My name is Heidi Bader and I am CFO at the company and I am here together with our CEO Magnus Larsson. Magnus, can you tell us a little bit about what has happened in the quarter?
Magnus Larsson
CEO
Yes, I can. Promimic is growing by 6% compared to the same period last year. We are growing by 17% year to date and we are showing a positive EBITDA. If we look at MPI, which is our process unit, it remains at the same level if you look at year-to-date. And we grow strongly on the royalty side, which has grown by 29% year-to-date.
Heidi Bader
CFO
Royalty and licenses are important for our revenues and in the quarter we have signed a new license agreement and also have ten new implants approved for clinical use in the quarter. Can you tell us more about this?
You're reading a preview of the PRO.ST Q3 2024 earnings call.
Free account.
Disclaimer